Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Macaca fascicularis | |||||||
GSE200368 |
Cynomolgus macaques: Young vs Elder
|
13 | Takahiro Tomiyama | May 04, 2024 | ||||
GSE250569 |
Preclinical study on safety and efficacy of GMP human umbilical cord mesenchymal stem cells in knee osteoarthritis
|
30 | Yan Yaping | May 01, 2024 | ||||
GSE262140 |
Atlas of Cynomolgus Macaque Hematopoiesis
|
36 | Ryo Yamamoto | Apr 26, 2024 | ||||
GSE253538 |
Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination
|
81 | Emilie Chautard | Mar 29, 2024 | ||||
GSE241293 |
Generation and characterization of inducible KRAB-dCas9 iPSCs from primates for cross-species CRISPRi
|
|
2 | Ines Hellmann | Mar 26, 2024 | |||
GSE200470 |
Divergent composition and transposon-silencing activity of small RNAs in mammalian oocytes
|
138 | Wei Liu | Mar 06, 2024 | ||||
GSE256418 |
Cell-mediated Immune Response Signature to AAV Capsid in Cynomolgus Monkeys
|
102 | Richard Virgen-Slane | Feb 26, 2024 | ||||
GSE255980 |
Generation and characterization of inducible KRAB-dCas9 iPSCs from primates for cross-species CRISPRi
|
|
68 | Wolfgang Enard | Feb 20, 2024 | |||
GSE208114 |
A Biodistribution Study of OTV vs. ASO by Intravenous or Intrathecal Administration in Cynomolgus Monkeys
|
9 | Thomas Sandmann | Feb 12, 2024 | ||||
GSE243657 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (LAM30 IgM)
|
|
196 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243658 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (LAM63 IgA)
|
|
270 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243659 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (LAM63 IgG)
|
|
270 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243660 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (NAPPA IgA)
|
|
261 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243661 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (NAPPA IgG)
|
|
261 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243663 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates
|
|
1258 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE180906 |
Obese Skeletal Muscle-Expressed Interferon Regulatory Factor 4 Transcriptionally Regulates Mitochondrial Branched-Chain Aminotransferase Reprogramming Metabolome
|
2 | Kong Xingxing | Dec 12, 2023 | ||||
GSE243731 |
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-g and NK cells [BALF_Macro_SARS_NHP]
|
21 | Nicolas Huot | Sep 25, 2023 | ||||
GSE243732 |
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-g and NK cells [BALF_NK_SARSWu_NHP]
|
20 | Nicolas Huot | Sep 25, 2023 | ||||
GSE243733 |
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-g and NK cells [BALF_BloodNK_SARSWu_NHP]
|
24 | Nicolas Huot | Sep 25, 2023 | ||||
GSE243734 |
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-g and NK cells
|
65 | Nicolas Huot | Sep 25, 2023 |